Obesity
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
In addition, plasma resistin level was associated with dyslipidaemia, serum insulin concentration and obesity.
|
19727657 |
2010 |
Obesity
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
We conclude that the recently described relationships of murine resistin/Fizz3 expression with obesity, insulin resistance, and PPAR-gamma action may not readily translate to humans.
|
11574398 |
2001 |
Obesity
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Visfatin/PBEF/Nampt and resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans.
|
20091460 |
2010 |
Obesity
|
0.100 |
Biomarker
|
disease |
BEFREE |
The adipokine resistin has been proposed to link obesity, insulin resistance and diabetes.
|
30353146 |
2018 |
Obesity
|
0.100 |
Biomarker
|
disease |
BEFREE |
Obesity is associated with an increased risk of colorectal cancer (CRC), and ghrelin (GHRL) and resistin (RETN) are thought to be related to obesity.
|
24585435 |
2014 |
Obesity
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Obesity is not associated with GCF and salivary resistin and TNF-α levels in children in the presence of gingival inflammation.
|
29635809 |
2018 |
Obesity
|
0.100 |
Biomarker
|
disease |
BEFREE |
This study was designed to estimate the possibility of utilizing psoriasin, nestin, keratin-16 (Krt16), and interleukin-21 (IL-21) as biochemical markers of psoriasis, to correlate these candidate psoriatic markers with biomarkers of obesity [body mass index (BMI), leptin, and resistin], and to elucidate the bidirectional association between obesity and psoriasis.
|
29252076 |
2018 |
Obesity
|
0.100 |
Biomarker
|
disease |
BEFREE |
Thus, the overproduction of obesity‑associated resistin and the associated amplification of the inflammatory response may result in the aggravation of AP severity.
|
27959400 |
2017 |
Obesity
|
0.100 |
Biomarker
|
disease |
BEFREE |
The recently characterized adipocyte hormone resistin (also called FIZZ3/ADSF) has been implicated as a molecular link between impaired glucose tolerance (IGT) and obesity in mice.
|
11978666 |
2002 |
Obesity
|
0.100 |
Biomarker
|
disease |
BEFREE |
The adipokine resistin is suggested to be an important link between obesity and insulin resistance.
|
15843582 |
2005 |
Obesity
|
0.100 |
Biomarker
|
disease |
BEFREE |
Although resistin was recently found to modulate insulin resistance in preclinical models of type II diabetes and obesity, recent studies also suggested that resistin has proinflammatory properties.
|
24719460 |
2014 |
Obesity
|
0.100 |
Biomarker
|
disease |
BEFREE |
Resistin may be an important link between obesity and diabetes.
|
25656506 |
2015 |
Obesity
|
0.100 |
Biomarker
|
disease |
BEFREE |
Several clinical and experimental studies have identified resistin as a key hormone linking insulin-resistance to obesity, notably through the activation of Toll Like Receptor (TLR) 4 signaling pathways.
|
30906281 |
2019 |
Obesity
|
0.100 |
Biomarker
|
disease |
BEFREE |
However, some recent genetic studies have demonstrated an association between resistin and insulin resistance and obesity.
|
12444887 |
2002 |
Obesity
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
In conclusion, this study confirms the expression of resistin in human adipose tissue and increased expression in abdominal fat, this suggests a potential role in linking central obesity to type 2 diabetes and/or cardiovascular disease.
|
11994397 |
2002 |
Obesity
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In this study, we hypothesized that mutations in the resistin encoding gene, RETN, may cause a monogenic form of obesity.
|
21441316 |
2011 |
Obesity
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Genetic variations of the human RETN gene are associated with metabolic phenotypes, including obesity, insulin sensitivity, diabetes, and coronary heart disease (CHD).
|
19381781 |
2009 |
Obesity
|
0.100 |
Biomarker
|
disease |
BEFREE |
Association of adiponectin, leptin and resistin with inflammatory markers and obesity in dementia.
|
28421328 |
2017 |
Obesity
|
0.100 |
Biomarker
|
disease |
BEFREE |
Resistin, an adipocyte secreted factor, has been suggested to link obesity with type 2 diabetes in rodent models, but its relevance to human diabetes remains uncertain.
|
14671216 |
2003 |
Obesity
|
0.100 |
Biomarker
|
disease |
BEFREE |
DNAJC27 was found to be associated with leptin and resistin, adipokines known to be dysregulated in obesity, that stimulate inflammatory processes leading to metabolic disorders.
|
30131766 |
2018 |
Obesity
|
0.100 |
Biomarker
|
disease |
BEFREE |
Resistin promotes hypothalamic neuroinflammation and insulin resistance through Toll like receptor 4 (TLR4), this hormone is thought to be a link between obesity and insulin-resistance.
|
30845245 |
2019 |
Obesity
|
0.100 |
Biomarker
|
disease |
BEFREE |
While resistin was first known as an adipocyte-secreted hormone (adipokine) linked to obesity and insulin resistance in rodents, it is predominantly expressed and secreted by macrophages in humans.
|
28192887 |
2017 |
Obesity
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Amplified resistin expression may indicate insulin-resistant type II diabetes and obesity are associated with AA breast cancer.
|
24324792 |
2013 |
Obesity
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The aim of this study was to investigate the association between the RANKL and c-Fos gene methylation on obesity with body mass index (BMI), lipid parameters, homeostasis model assessment of insulin resistance (HOMA-IR), plasma leptin, adiponectin and resistin levels.
|
31364017 |
2019 |
Obesity
|
0.100 |
Biomarker
|
disease |
BEFREE |
Resistin (<i>RETN</i>) is an adipokine that is associated with obesity, inflammation, and various cancers.
|
30406149 |
2018 |